Correlation Between Xvivo Perfusion and Bactiguard Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xvivo Perfusion and Bactiguard Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xvivo Perfusion and Bactiguard Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xvivo Perfusion AB and Bactiguard Holding AB, you can compare the effects of market volatilities on Xvivo Perfusion and Bactiguard Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xvivo Perfusion with a short position of Bactiguard Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xvivo Perfusion and Bactiguard Holding.

Diversification Opportunities for Xvivo Perfusion and Bactiguard Holding

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Xvivo and Bactiguard is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Xvivo Perfusion AB and Bactiguard Holding AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bactiguard Holding and Xvivo Perfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xvivo Perfusion AB are associated (or correlated) with Bactiguard Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bactiguard Holding has no effect on the direction of Xvivo Perfusion i.e., Xvivo Perfusion and Bactiguard Holding go up and down completely randomly.

Pair Corralation between Xvivo Perfusion and Bactiguard Holding

Assuming the 90 days trading horizon Xvivo Perfusion AB is expected to generate 0.73 times more return on investment than Bactiguard Holding. However, Xvivo Perfusion AB is 1.37 times less risky than Bactiguard Holding. It trades about -0.06 of its potential returns per unit of risk. Bactiguard Holding AB is currently generating about -0.36 per unit of risk. If you would invest  52,300  in Xvivo Perfusion AB on August 31, 2024 and sell it today you would lose (5,050) from holding Xvivo Perfusion AB or give up 9.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Xvivo Perfusion AB  vs.  Bactiguard Holding AB

 Performance 
       Timeline  
Xvivo Perfusion AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Bactiguard Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bactiguard Holding AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Xvivo Perfusion and Bactiguard Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xvivo Perfusion and Bactiguard Holding

The main advantage of trading using opposite Xvivo Perfusion and Bactiguard Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xvivo Perfusion position performs unexpectedly, Bactiguard Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bactiguard Holding will offset losses from the drop in Bactiguard Holding's long position.
The idea behind Xvivo Perfusion AB and Bactiguard Holding AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities